On the 14th, Easton Pharmaceuticals’ class 3 generic drug, Glycopyrrolate Bromide Injection, entered the "under review" stage and is expected to be officially approved in the near future.
On the 14th, Easton Pharmaceuticals' Class 3 generic drug Glycopyrrolate Bromide Injection application entered the "on-approval" phase and is expected to be formally approved in the near future.
On the 14th, Easton pharmaceuticals' Class 3 generic drug, glycopyrrolate Bromid injection, entered the "under approval" stage and is expected to be officially approved in the near future,<br>